The way to build bridges instead of walls is still long, but I am happy to have got European Union funding for this project. Africlinique project aims to increase the capacity to oversight clinical trials addressing deadly diseases in Central African countries (specifically Republic of the Congo, Democratic Republic of the Congo, Cameroon and Gabon). This achievement was made possible thanks to the exciting proactiveness and invaluable collaboration of a Central African team lead by Prof. Francine Ntoumi, already coordinator of Central Africa Network on Tuberculosis, HIV/AIDS and Malaria (CANTAM).

Leave a Reply

Your email address will not be published. Required fields are marked *

Explore More

SUPER

The SUPER project will provide capacity building at the regulatory and ethics level for National Regulatory Authority, National and Institutional Ethics Committees, with the ultimate goal to strengthen an environement

Read More

EVD68-VAXREADY: A decisive step forward for European epidemic preparedness and viral emergency response

Emerging and re-emerging viral infections represent one of the most complex challenges for global public health. Among these, Enterovirus D68 (EV-D68) is emerging with increasing urgency due to recurring outbreaks

Read More

Ebola vaccines at a la glance

Ebola vaccine candidates are currently being evaluated in phase I–III clinical trials conducted in Africa, the EU and the US. Although preclinical development of candidate vaccines utilise different platforms, including

Read More